Thomas Schuetz is Chief Executive Officer of Compass Therapeutics, Inc. (CMPX). The company reported total compensation of $5,097,150 for fiscal year 2025.
| Salary | $630,000 |
|---|---|
| Bonus | $381,150 |
| Stock awards | $0 |
| Option awards | $4,065,000 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $21,000 |
| Total | $5,097,150 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Compass Therapeutics, Inc. filed April 29, 2026, accession 0001140361-26-017649.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer | $630,000 | $381,150 | $0 | $4,065,000 | $0 | $0 | $21,000 | $5,097,150 |
| FY2024 | Chief Executive Officer | $575,000 | $400,000 | $1,230,375 | $867,882 | $0 | $0 | $19,800 | $3,093,057 |
Totals as disclosed in each year's own compensation disclosure for Compass Therapeutics, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Thomas Schuetz this page | Chief Executive Officer | $5,097,150 |
| Jonathan Anderman | General Counsel and Corporate Secretary | $1,427,800 |
| Barry Shin | Chief Financial Officer | $1,394,500 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Compass Therapeutics, Inc. compensation brief.
Thomas Schuetz's compensation sits inside Compass Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.